The two fold role of oxytocin in social developmental disorders: A cause and a remedy?

Neuroscience and Biobehavioral Reviews

Volumn 63, Issue , 2016, Pages 168-176

  Lefevre, Arthur ^a   Sirigu, Angela ^a  

^a INSTITUT DES SCIENCES COGNITIVES   (France)

Author keywords

Autism; Early life experience; Labor induction; Oxytocin; Social behavior

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; OPIATE; OXYTOCIN; PROTEIN C FOS; SEROTONIN; VASOPRESSIN; OXTR PROTEIN, HUMAN; OXYTOCIN RECEPTOR;

ANTISOCIAL PERSONALITY DISORDER; AUTISM; BOLD SIGNAL; DEVELOPMENTAL STAGE; DISEASE CLASSIFICATION; DNA METHYLATION; HUMAN; LABOR INDUCTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; SOCIAL STATUS; UPREGULATION; ANIMAL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; INFANT; INTRANASAL DRUG ADMINISTRATION; MALE; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; AUTISM SPECTRUM DISORDER; BRAIN; FEMALE; HUMANS; INFANT; MALE; OXYTOCIN; RECEPTORS, OXYTOCIN; SOCIAL BEHAVIOR DISORDERS;

EID: 84958238031     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.01.011     Document Type: Review

References (93)

1. Anagnostou E., Soorya L., Chaplin W., Bartz J., Halpern D., Wasserman S., Wang A.T., Pepa L., Tanel N., Kushki A., Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol. Autism 2012, 3:16. 10.1186/2040-2392-3-16.
2. Andari E., Duhamel J.-R., Zalla T., Herbrecht E., Leboyer M., Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc. Natl. Acad. Sci. U. S. A 2010, 107:4389-4394. 10.1073/pnas.0910249107.
3. Apter-Levy Y., Feldman M., Vakart A., Ebstein R.P., Feldman R. Impact of maternal depression across the first 6 years of life on the child's mental health, social engagement, and empathy: the moderating role of oxytocin. Am. J. Psychiatry 2013, 170:1161-1168. 10.1176/appi.ajp.2013.12121597.
4. Bakermans-Kranenburg M.J., van IJzendoorn M.H. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl. Psychiatry 2013, 3:e258. 10.1038/tp.2013.34.
5. Bales K.L., Carter C.S. Developmental exposure to oxytocin facilitates partner preferences in male prairie voles (Microtus ochrogaster). Behav. Neurosci. 2003, 117:854-859.
6. Bales K.L., Carter C.S. Sex differences and developmental effects of oxytocin on aggression and social behavior in prairie voles (Microtus ochrogaster). Horm. Behav. 2003, 44:178-184.
7. Bales K.L., Perkeybile A.M. Developmental experiences and the oxytocin receptor system. Horm. Behav. 2012, 61:313-319. 10.1016/j.yhbeh.2011.12.013.
8. Bales K.L., Pfeifer L.A., Carter C.S. Sex differences and developmental effects of manipulations of oxytocin on alloparenting and anxiety in prairie voles. Dev. Psychobiol. 2004, 44:123-131. 10.1002/dev.10165.
9. Bales K.L., Plotsky P.M., Young L.J., Lim M.M., Grotte N., Ferrer E., Carter C.S. Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptors. Neuroscience 2007, 144:38-45. 10.1016/j.neuroscience.2006.09.009.
10. Bales K.L., van Westerhuyzen J.A., Lewis-Reese A.D., Grotte N.D., Lanter J.A., Carter C.S. Oxytocin has dose-dependent developmental effects on pair-bonding and alloparental care in female prairie voles. Horm. Behav. 2007, 52:274-279. 10.1016/j.yhbeh.2007.05.004.
11. Bales K.L., Boone E., Epperson P., Hoffman G., Carter C.S. Are behavioral effects of early experience mediated by oxytocin?. Front. Psychiatry 2011, 2:24. 10.3389/fpsyt.2011.00024.
12. Bales K.L., Perkeybile A.M., Conley O.G., Lee M.H., Guoynes C.D., Downing G.M., Yun C.R., Solomon M., Jacob S., Mendoza S.P. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol. Psychiatry 2013, 74:180-188. 10.1016/j.biopsych.2012.08.025.
13. Bales K.L., Solomon M., Jacob S., Crawley J.N., Silverman J.L., Larke R.H., Sahagun E., Puhger K.R., Pride M.C., Mendoza S.P. Long-term exposure to intranasal oxytocin in a mouse autism model. Transl. Psychiatry 2014, 4:e480. 10.1038/tp.2014.117.
14. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309. 10.1016/j.tics.2011.05.002.
15. Baskerville T.A., Douglas A.J. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci. Ther. 2010, e92-e123. 10.1111/j.1755-5949.2010.00154. x.
16. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 2002, 5:514-516. 10.1038/nn0602-849.
17. Bowen M.T., Carson D.S., Spiro A., Arnold J.C., McGregor I.S. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS One 2011, 6:e27237. 10.1371/journal.pone.0027237.
18. Brown C.H., Russell J.A., Leng G. Opioid modulation of magnocellular neurosecretory cell activity. Neurosci. Res. 2000, 36:97-120.
19. Buijs R.M., Geffard M., Pool C.W., Hoorneman E.M.D. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res. 1984, 323:65-72. 10.1016/0006-8993(84) 90265-8.
20. Busnelli M., Bulgheroni E., Manning M., Kleinau G., Chini B. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors. J. Pharmacol. Exp. Ther. 2013, 10.1124/jpet.113.202994.
21. Calcagnoli F., Meyer N., de Boer S.F., Althaus M., Koolhaas J.M. Chronic enhancement of brain oxytocin levels causes enduring anti-aggressive and pro-social explorative behavioral effects in male rats. Horm. Behav. 2014, 10.1016/j.yhbeh.2014.03.008.
22. Calcagnoli F., Kreutzmann J.C., de Boer S.F., Althaus M., Koolhaas J.M. Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats. Psychoneuroendocrinology 2015, 51:112-121. 10.1016/j.psyneuen.2014.09.019.
23. Clark C.L., St.John N., Pasca A.M., Hyde S.A., Hornbeak K., Abramova M., Feldman H., Parker K.J., Penn A.A. Neonatal CSF oxytocin levels are associated with parent report of infant soothability and sociability. Psychoneuroendocrinology 2013, 38:1208-1212. 10.1016/j.psyneuen.2012.10.017.
24. Connelly Jessica, J., Morris James, P., Jacob, Bales Karen, C. Sue, 2013. Individual differences in oxytocin receptor DNA methylation are related to indices of social behavior in humans and voles., WNCH, 2013 poster presentation.
25. Csiffáry A., Ruttner Z., Tóth Z., Palkovits M. Oxytocin nerve fibers innervate beta-endorphin neurons in the arcuate nucleus of the rat hypothalamus. Neuroendocrinology 1992, 56:429-435.
26. Curley J.P., Jensen C.L., Mashoodh R., Champagne F.A. Social influences on neurobiology and behavior: epigenetic effects during development. Psychoneuroendocrinology 2011, 36:352-371. 10.1016/j.psyneuen.2010.06.005.
27. Cushing B.S., Yamamoto Y., Hoffman G.E., Carter C.S. Central expression of c-Fos in neonatal male and female prairie voles in response to treatment with oxytocin. Brain Res. Dev. Brain Res 2003, 143:129-136.
28. Cushing B.S., Levine K., Cushing N.L. Neonatal manipulation of oxytocin influences female reproductive behavior and success. Horm. Behav. 2005, 47:22-28. 10.1016/j.yhbeh.2004.08.004.
29. Dölen G., Darvishzadeh A., Huang K.W., Malenka R.C. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 2013, 501:179-184. 10.1038/nature12518.
30. Eaton J.L., Roache L., Nguyen K.N., Cushing B.S., Troyer E., Papademetriou E., Raghanti M.A. Organizational effects of oxytocin on serotonin innervation. Dev. Psychobiol. 2012, 54:92-97. 10.1002/dev.20566.
31. Emiliano A.B.F., Cruz T., Pannoni V., Fudge J.L. The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for ssris therapeutic effects?. Neuropsychopharmacology 2007, 32:977-988. 10.1038/sj.npp.1301206.
32. Gimpl G., Fahrenholz F. The oxytocin receptor system structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
33. Gregory S.G., Anthopolos R., Osgood C.E., Grotegut C.A., Miranda M.L. Association of autism with induced or augmented childbirth in north Carolina birth record (1990-1998) and education research (1997-2007) databases. JAMA Pediatr. 2013, 167:959-966. 10.1001/jamapediatrics.2013.2904.
34. Gregory S.G., Connelly J.J., Towers A.J., Johnson J., Biscocho D., Markunas C.A., Lintas C., Abramson R.K., Wright H.H., Ellis P., Langford C.F., Worley G., Delong G.R., Murphy S.K., Cuccaro M.L., Persico A., Pericak-Vance M.A. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 2009, 7:62. 10.1186/1741-7015-7-62.
35. Groppe S.E., Gossen A., Rademacher L., Hahn A., Westphal L., Gründer G., Spreckelmeyer K.N. Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol. Psychiatry 2013, 74:172-179. 10.1016/j.biopsych.2012.12.023.
36. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694. 10.1016/j.biopsych.2009.09.020.
37. Guastella A.J., Gray K.M., Rinehart N.J., Alvares G.A., Tonge B.J., Hickie I.B., Keating C.M., Cacciotti-Saija C., Einfeld S.L. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J. Child Psychol. Psychiatry 2014, 10.1111/jcpp.12305.
38. Guinchat V., Thorsen P., Laurent C., Cans C., Bodeau N., Cohen D. Pre-, peri- and neonatal risk factors for autism. Acta Obstet. Gynecol. Scand. 2012, 91:287-300. 10.1111/j.1600-0412.2011.01325.x.
39. Hammock E., Veenstra-VanderWeele J., Yan Z., Kerr T.M., Morris M., Anderson G.M., Carter C.S., Cook E.H., Jacob S. Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51. 7121-721e1. 10.1016/j.jaac.2012.04.010.
40. Hashemi F., Tekes K., Laufer R., Szegi P., Tóthfalusi L., Csaba G. Effect of a single neonatal oxytocin treatment (hormonal imprinting) on the biogenic amine level of the adult rat brain: could oxytocin-induced labor cause pervasive developmental diseases?. Reprod. Sci. 2013, 20:1255-1263. 10.1177/1933719113483010.
41. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol. Psychiatry 2009, 14:954-958. 10.1038/mp.2008.112.
42. Huang H., Michetti C., Busnelli M., Managò F., Sannino S., Scheggia D., Giancardo L., Sona D., Murino V., Chini B., Luisa Scattoni M., Papaleo F. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 2013, 10.1038/npp.2013.310.
43. Huber D., Veinante P., Stoop R. VAsopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308:245-248. 10.1126/science.1105636.
44. Jack A., Connelly J.J., Morris J.P. DNA methylation of the oxytocin receptor gene predicts neural response to ambiguous social stimuli. Front. Hum. Neurosci. 2012, 6:280. 10.3389/fnhum.2012.00280.
45. Jia R., Tai F., An S., Broders H., Sun R. Neonatal manipulation of oxytocin influences the partner preference in mandarin voles (Microtus mandarinus). Neuropeptides 2008, 42:525-533. 10.1016/j.npep.2008.06.001.
46. Jia R., Tai F.D., An S.C., Broders H., Ding X.L., Kong Q., Zhao L., Zhang H. Effects of neonatal oxytocin treatment on aggression and neural activities in mandarin voles. Physiol. Behav. 2008, 95:56-62. 10.1016/j.physbeh.2008.04.015.
47. Martin, Joyce A., Brady, E., Paul, D. Sutton, J. Ventura, Stephanie, Menacker, Sharon, Mathews, 2009. Births: Final Data for 2006 [WWW Document]. URL /> (accessed 10.22.13.). http://www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_07.pdf.
48. Kramer K.M., Cushing B.S., Carter C.S. Developmental effects of oxytocin on stress response: single versus repeated exposure. Physiol. Behav 2003, 79:775-782.
49. Kramer K.M., Choe C., Carter C.S., Cushing B.S. Developmental effects of oxytocin on neural activation and neuropeptide release in response to social stimuli. Horm. Behav. 2006, 49:206-214. 10.1016/j.yhbeh.2005.07.001.
50. Kurth L., Haussmann R. Perinatal Pitocin as an early ADHD biomarker: neurodevelopmental risk?. J. Atten. Disord. 2011, 15:423-431. 10.1177/1087054710397800.
51. Lefevre, A., Janet, R., Mottolese, R., Andari, A., Leboyer, M., Sirigu, A., n.d. Uncorrelated judgments of sociability between autistic patients and their parents Prep.
52. Leng G., Ludwig M. Intranasal oxytocin: myths and delusions. Biol. Psychiatry 2015, 10.1016/j.biopsych.2015.05.003.
53. Love T.M. Oxytocin, motivation and the role of dopamine. Pharmacol. Biochem. Behav. 2013, 10.1016/j.pbb.2013.06.011.
54. Lovic V., Gonzalez A., Fleming A.S. Maternally separated rats show deficits in maternal care in adulthood. Dev. Psychobiol. 2001, 39:19-33.
55. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 2006, 7:126-136. 10.1038/nrn1845.
56. Marlin B.J., Mitre M., Damour J.A., Chao M.V., Froemke R.C. Oxytocin enables maternal behaviour by balancing cortical inhibition. Nature 2015, 10.1038/nature14402.
57. Modahl C., Green L., Fein D., Morris M., Waterhouse L., Feinstein C., Levin H. Plasma oxytocin levels in autistic children. Biol. Psychiatry 1998, 43:270-277.
58. Modi M.E., Connor-Stroud F., Landgraf R., Young L.J., Parr L.A. Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques. Psychoneuroendocrinology 2014, 45:49-57. 10.1016/j.psyneuen.2014.02.011.
59. Mottolese R., Redouté J., Costes N., Le Bars D., Sirigu A. Switching brain serotonin with oxytocin. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:8637-8642. 10.1073/pnas.1319810111.
60. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmühl Y., Fischer D., Holsboer F., Wotjak C.T., Almeida O.F.X., Spengler D. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci. 2009, 12:1559-1566. 10.1038/nn.2436.
61. NA Committee opinion no. 597: labor induction or augmentation and autism. Obstet. Gynecol. 2014, 123:1140-1142. 10.1097/01AOG.0000446827.54456.89.
62. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659. 10.1016/j.tins.2012.08.004.
63. Neumann I.D., Maloumby R., Beiderbeck D.I., Lukas M., Landgraf R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 2013, 10.1016/j.psyneuen.2013.03.003.
64. Oscarsson M.E., Amer-Wåhlin I., Rydhstroem H., Källén K. Outcome in obstetric care related to oxytocin use. A population-based study. Acta Obstet. Gynecol. Scand. 2006, 85:1094-1098. 10.1080/00016340600804530.
65. Owen S.F., Tuncdemir S.N., Bader P.L., Tirko N.N., Fishell G., Tsien R.W. Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 2013, 500:458-462. 10.1038/nature12330.
66. Pagani J.H., Williams Avram S.K., Cui Z., Song J., Mezey É., Senerth J.M., Baumann M.H., Young W.S. Raphe serotonin neuron-specific oxytocin receptor knockout reduces aggression without affecting anxiety-like behavior in male mice only. Genes Brain Behav. 2015, 10.1111/gbb.12202.
67. Peters S., Slattery D.A., Uschold-Schmidt N., Reber S.O., Neumann I.D. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology 2014, 42:225-236. 10.1016/j.psyneuen.2014.01.021.
68. Quintana D.S., Alvares G.A., Hickie I.B., Guastella A.J. Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model. Neurosci. Biobehav. Rev. 2014, 10.1016/j.neubiorev.2014.12.011.
69. Quintana D.S., Westlye L.T., Rustan Ø.G., Tesli N., Poppy C.L., Smevik H., Tesli M., Røine M., Mahmoud R.A., Smerud K.T., Djupesland P.G., Andreassen O.A. Low-dose oxytocin delivered intranasally with breath powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. Transl. Psychiatry 2015, 5:e602. 10.1038/tp.2015.93.
70. Rault J.-L., Carter C.S., Garner J.P., Marchant-Forde J.N., Richert B.T., Lay D.C. Repeated intranasal oxytocin administration in early life dysregulates the HPA axis and alters social behavior. Physiol. Behav. 2013, 112-113:40-48. 10.1016/j.physbeh.2013.02.007.
71. Sikich, L., et al., 2013. 2013 International Meeting for Autism Research: Extended Oxytocin Treatment of Children with Autistic Disorder [WWW Document] URL /> (accessed 11.5.13.). http://https://imfar.confex.com/imfar/2013/webprogram/Paper14701.html.
72. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61. 10.1016/j.neuropharm.2009.06.038.
73. Song Z., McCann K.E., McNeill J.K., Larkin T.E., Huhman K.L., Albers H.E. Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors. Psychoneuroendocrinology 2014, 50C:14-19. 10.1016/j.psyneuen.2014.08.005.
74. Tachibana M., Kagitani-Shimono K., Mohri I., Yamamoto T., Sanefuji W., Nakamura A., Oishi M., Kimura T., Onaka T., Ozono K., Taniike M. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J. Child Adolesc. Psychopharmacol. 2013, 23:123-127. 10.1089/cap.2012.0048.
75. Teng B.L., Nonneman R.J., Agster K.L., Nikolova V.D., Davis T.T., Riddick N.V., Baker L.K., Pedersen C.A., Jarstfer M.B., Moy S.S. Prosocial effects of oxytocin in two mouse models of autism spectrum disorders. Neuropharmacology 2013, 72:187-196. 10.1016/j.neuropharm.2013.04.038.
76. Tyzio R., Cossart R., Khalilov I., Minlebaev M., Hübner C.A., Represa A., Ben-Ari Y., Khazipov R. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science 2006, 314:1788-1792. 10.1126/science.1133212.
77. Tyzio R., Nardou R., Ferrari D.C., Tsintsadze T., Shahrokhi A., Eftekhari S., Khalilov I., Tsintsadze V., Brouchoud C., Chazal G., Lemonnier E., Lozovaya N., Burnashev N., Ben-Ari Y. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014, 343:675-679. 10.1126/science.1247190.
78. Vaccari C., Lolait S.J., Ostrowski N.L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 1998, 139:5015-5033. 10.1210/en.139.12.5015.
79. Veenema A.H. Toward understanding how early-life social experiences alter oxytocin- and vasopressin-regulated social behaviors. Horm. Behav. 2012, 61:304-312. 10.1016/j.yhbeh.2011.12.002.
80. Vintzileos A.M., Ananth C.V. Does augmentation or induction of labor with oxytocin increase the risk for autism?. Am. J. Obstet. Gynecol. 2013, 10.1016/j.ajog.2013.09.003.
81. Wahl R.U.R. Could oxytocin administration during labor contribute to autism and related behavioral disorders? A look at the literature. Med. Hypotheses 2004, 63:456-460. 10.1016/j.mehy.2004.03.008.
82. Watanabe T., Kuroda M., Kuwabara H., Aoki Y., Iwashiro N., Tatsunobu N., Takao H., Nippashi Y., Kawakubo Y., Kunimatsu A., Kasai K., Yamasue H. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain J. Neurol. 2015, 10.1093/brain/awv249.
83. Weisman O., Agerbo E., Carter C.S., Harris J.C., Uldbjerg N., Henriksen T.B., Thygesen M., Mortensen P.B., Leckman J.F., Dalsgaard S. Oxytocin-augmented labor and risk for autism in males. Behav. Brain Res. 2015, 10.1016/j.bbr.2015.02.028.
84. Witt D.M., Winslow J.T., Insel T.R. Enhanced social interactions in rats following chronic: centrally infused oxytocin. Pharmacol. Biochem. Behav. 1992, 43:855-861.
85. Xu X.-J., Shou X.-J., Li J., Jia M.-X., Zhang J.-S., Guo Y., Wei Q.-Y., Zhang X.-T., Han S.-P., Zhang R., Han J.-S. Mothers of autistic children: lower plasma levels of oxytocin and arg-vasopressin and a higher level of testosterone. PLoS One 2013, 8:e74849. 10.1371/journal.pone.0074849.
86. Yamamoto Y., Cushing B.S., Kramer K.M., Epperson P.D., Hoffman G.E., Carter C.S. Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience 2004, 125:947-955. 10.1016/j.neuroscience.2004.02.028.
87. Yamamoto Y., Carter C.S., Cushing B.S. Neonatal manipulation of oxytocin affects expression of estrogen receptor alpha. Neuroscience 2006, 137:157-164. 10.1016/j.neuroscience.2005.08.065.
88. Yang C.-J., Tan H.-P., Du Y.-J. The developmental disruptions of serotonin signaling may involved in the autism during early brain development. Neuroscience 2014, 10.1016/j.neuroscience.2014.02.021.
89. Yatawara C.J., Einfeld S.L., Hickie I.B., Davenport T.A., Guastella A.J. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol. Psychiatry 2015, 10.1038/mp.2015.162.
90. Yoshida M., Takayanagi Y., Inoue K., Kimura T., Young L.J., Onaka T., Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J. Neurosci. 2009, 29:2259-2271. 10.1523/JNEUROSCI.5593-08.2009.
91. Young L.J., Flanagan-Cato L.M. Editorial comment: oxytocin, vasopressin and social behavior. Horm. Behav. 2012, 61:227-229. 10.1016/j.yhbeh.2012.02.019.
92. Young L.J., Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 2004, 7:1048-1054. 10.1038/nn1327.
93. Young E., Carter C.S., Cushing B.S., Caldwell J.D. Neonatal manipulation of oxytocin alters oxytocin levels in the pituitary of adult rats. Horm. Metab. Res. 2005, 37:397-401. 10.1055/s-2005-870227.